Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma
This study is currently recruiting participants.
Study NCT00670358
Information provided by National Cancer Institute (NCI)
First Received: April 30, 2008
Last Updated: August 4, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
